John T. Cavan, Chief Financial Officer at Hepion Pharmaceuticals, Inc. (HEPA), bought 10,000 shares at $2.00 ($20K) on 2021-02-18, disclosed to the SEC on 2021-02-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |